Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Infectious Diseases
Volume 2017 (2017), Article ID 2941527, 4 pages
https://doi.org/10.1155/2017/2941527
Case Report

Saccharomyces cerevisiae Laryngitis and Oral Lesions in a Patient with Laryngeal Carcinoma

1Department of Health Sciences International, The University of California, San Diego, CA, USA
2Division of Infectious Diseases, The University of California, San Diego, CA, USA
3Division of Pathology, University of Texas MD Anderson Cancer Center, Houston, TX, USA

Correspondence should be addressed to Ajay R. Bharti; ude.dscu@itrahba

Received 12 May 2017; Revised 4 October 2017; Accepted 24 October 2017; Published 26 November 2017

Academic Editor: Gernot Walder

Copyright © 2017 Jumanah N. Algazaq et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. G. Billoo, M. A. Memon, S. A. Khaskheli et al., “Role of a probiotic (Saccharomyces boulardii) in management and prevention of diarrhoea,” World Journal of Gastroenterology, vol. 12, no. 28, pp. 4557–4560, 2006. View at Publisher · View at Google Scholar
  2. B. Posteraro, M. Sanguinetti, G. D’Amore, L. Masucci, G. Morace, and G. Fadda, “Molecular and epidemiological characterization of vaginal Saccharomyces cerevisiae isolates,” Journal of Clinical Microbiology, vol. 37, no. 7, pp. 2230–2235, 1999. View at Google Scholar
  3. P. Munoz, E. Bouza, M. Cuenca-Estrella et al., “Saccharomyces cerevisiae fungemia: an emerging infectious disease,” Clinical Infectious Diseases, vol. 40, no. 11, pp. 1625–1634, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. M. Cuenca-Estrella, W. Lee-Yang, M. A. Ciblak et al., “Comparative evaluation of NCCLS M27-A and EUCAST broth microdilution procedures for antifungal susceptibility testing of Candida species,” Antimicrobial Agents and Chemotherapy, vol. 46, no. 11, pp. 3644–3647, 2002. View at Publisher · View at Google Scholar · View at Scopus
  5. S. Henry, L. D’Hondt, M. Andre, X. Holemans, and J. L. Canon, “Saccharomyces cerevisiae fungemia in a head and neck cancer patient: a case report and review of the literature,” Acta Clinica Belgica, vol. 59, no. 4, pp. 220–222, 2004. View at Publisher · View at Google Scholar
  6. R. V. Lalla, M. C. Latortue, C. H. Hong et al., “A systematic review of oral fungal infections in patients receiving cancer therapy,” Supportive Care in Cancer, vol. 18, no. 8, pp. 985–992, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. S. Cesaro, P. Chinello, L. Rossi, and L. Zanesco, “Saccharomyces cerevisiae fungemia in a neutropenic patient treated with Saccharomyces boulardii,” Supportive Care in Cancer, vol. 8, no. 6, pp. 504-505, 2000. View at Publisher · View at Google Scholar
  8. W. J. Olver, S. A. James, A. Lennard et al., “Nosocomial transmission of Saccharomyces cerevisiae in bone marrow transplant patients,” Journal of Hospital Infection, vol. 52, no. 4, pp. 268–272, 2002. View at Publisher · View at Google Scholar · View at Scopus
  9. C. M de Ponzzes-Gomes, D. L. de Melo, C. A. Santana et al., “Saccharomyces cerevisiae and non-Saccharomyces yeasts in grape varieties of the Sao Francisco Valley,” Brazilian Journal of Microbiology, vol. 45, no. 2, pp. 411–416, 2014. View at Publisher · View at Google Scholar · View at Scopus
  10. I. Khatri, R. Tomar, K. Ganesan, G. S. Prasad, and S. Subramanian, “Complete genome sequence and comparative genomics of the probiotic yeast Saccharomyces boulardii,” Scientific Reports, vol. 7, no. 1, p. 371, 2017. View at Publisher · View at Google Scholar
  11. M. C. Appel-da-Silva, G. A. Narvaez, L. R. R. Perez, L. Drehmer, and J. Lewgoy, “Saccharomyces cerevisiae var. boulardii fungemia following probiotic treatment,” Medical Mycology Case Reports, vol. 18, pp. 15–17, 2017. View at Publisher · View at Google Scholar
  12. C. Cassagne, A. C. Normand, L. Bonzon et al., “Routine identification and mixed species detection in 6,192 clinical yeast isolates,” Medical Mycology, vol. 54, no. 3, pp. 256–265, 2016. View at Publisher · View at Google Scholar · View at Scopus
  13. A. Enache-Angoulvant and C. Hennequin, “Invasive Saccharomyces infection: a comprehensive review,” Clinical Infectious Diseases, vol. 41, no. 11, pp. 1559–1568, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Cassone, P. Serra, F. Mondello et al., “Outbreak of Saccharomyces cerevisiae subtype boulardii fungemia in patients neighboring those treated with a probiotic preparation of the organism,” Journal of Clinical Microbiology, vol. 41, no. 11, pp. 5340–5343, 2003. View at Publisher · View at Google Scholar · View at Scopus
  15. S. H. Yi, J. A. Jernigan, and L. C. McDonald, “Prevalence of probiotic use among inpatients: a descriptive study of 145 U.S. hospitals,” American Journal of Infection Control, vol. 44, no. 5, pp. 548–553, 2016. View at Publisher · View at Google Scholar · View at Scopus